Company intelligence / Profile preview

Avi-Mex

Mexico City, Ciudad de México, Mexicoars.usda.gov ↗
Ownership
Private
Development stage
Commercial
01

Overview

Avi-Mex has developed a recombinant NDV-vectored COVID‑19 vaccine ("Patria") that reached Phase 3 clinical trials and showed effectiveness as a booster. The program is supported by Mexican government funding and collaboration with CastleVax for the underlying technology. Manufacturing scale-up was planned pending regulatory approval from Cofepris and potential international recognition by WHO.

Therapeutic areas
Infectious Diseases
Modalities
VaccineRecombinant proteinGenetically engineered subunit vaccineProphylactic vaccine
Industry
Biotech
02

Drug pipeline

4 assets

Patria

3

3 more assets in the full pipeline.

Request access →
03

Partnerships

CastleVax Inc. — technology licensing partner for the NDV-based human COVID‑19 booster ("Patria")National Council of Humanities, Sciences and Technologies of Mexico ("Conacyt") — major funder/collaborator on Patria project

Beyond the preview

Go deeper on Avi-Mex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avi-Mex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call